Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
By H. Hartgrink, H. VeldevandeC.J., H. Putter, J. Bonenkamp, E. Kranenbarg, I. Songun, K. Welvaart, J. H. Krieken, S. Meijer, J. Plukker and 9 more. Journal of Clinical Oncology, 2004
879 citations recorded by the source corpus.
Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/3cb2791ae579701d2ee7301a2964a77b6d457237
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- S. Smalley
- J. Benedetti
- D. Haller
- J. Macdonald
- N. C. Estes
- S. Hundahl
- J. Ajani
- L. Gunderson
Citations in the corpus
- Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. (2012, background): “Furthermore, several reports of D2 surgery continue to observe substantial LRF.”